Search results
Aldosterone Synthase Inhibitors
Author(s):
Shubh K Patel
,
Hwee Teoh
,
Ahreni Saunthar
,
et al
Added:
8 months ago
Review Article
Aldosterone and Potassium in Heart Failure
Author(s):
Laibah Arshad Khan
,
Adeena Jamil
,
Stephen J Greene
,
et al
Added:
1 year ago
Review Article
ARNI for Optimising HFrEF Management
Author(s):
Massimo Iacoviello
,
Filippo M Sarullo
,
Claudio Bilato
,
et al
Added:
9 months ago
Expert Opinion
Author(s):
Vijay Chopra
Added:
11 months ago
Guest Editor Dr Vijay Chopra discusses the motivation behind the newly curated Special Focus on mineralocorticoid receptor antagonists.Dr Chopra explores why this topic is more relevant than ever, particularly as the field moves beyond traditional aldosterone antagonists toward novel agents like finerenone and aldosterone synthase inhibitors.From addressing hyperkalaemia fears to identifying gaps…
View more
SGLT-2 Inhibitors and Heart Failure
Author(s):
C Noah Nilsson
,
Mads Kristian Ersbøll
,
Finn Gustafsson
Added:
1 year ago
Review Article
Mineralocorticoid Receptor Antagonists in Heart Failure
Author(s):
Rishi Sethi
,
Pravesh Vishwakarma
,
Akshyaya Pradhan
Added:
1 year ago
Review Article
Author(s):
Antonio Méndez-Durán
,
Juan B Ivey-Miranda
,
Genaro H Mendoza-Zavala
,
et al
Added:
1 week ago
Author(s):
Thomas Modine
Added:
11 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Conduction System Pacing: A Fresh Look
Author(s):
Óscar Cano, Marek Jastrzębski, Pugazhendhi Vijayaraman
Start date:
Nov 13, 2024
Broadcast
